Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Our...
[vc_row css=".vc_custom_1713768007988{background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}"][vc_column width="1/2"][vc_column_text]At NATCO, we hold a leading market share in the...
Natco Pharma Limited Registered Office and Corporate Headquarters Natco House Road No.2, Banjara Hills Hyderabad-500 034, India +91-40-2354 7532 +91-40-2354 5298/23548243 www.natcopharma.com
Headquartered in Hyderabad, India, Natco has six formulation locations across India – two in Dehradun (Uttarakhand), one in Kothur (Mahboobnagar, Telangana), one in Nagarjuna Sagar (Nalgonda Dist, Telangana), one in Visakapatnam (Andhra Pradesh),...
NATCO has over 30 years of expertise in formulating innovative dosage forms. NATCO today is leveraging on this expertise to go global by exporting finished dosage products to various markets across the globe. Our partnership-driven business model...
Natco is well recognized as a high quality contract manufacturing company to many leading pharmaceutical firms in India. This is supported at Natco by its high inclination towards quality systems and state-of-the-art facilities. Natco...
NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...
NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...
The Pharma specialities division deals with products related to Orthopaedics and Gastroenterology. The orthopaedics range covers all the important Bisphosphonates, including the oral and injectable drugs. All of them are segment first introductions...
Welcome to the Natco Pharma Limited web site. The information provided on this site is for general information and business purposes only. Please read and review these Terms and conditions carefully before accessing or using this Web site. By...
We, Natco Pharma Limited, adopted this Privacy Policy with respect to collection, use, storage and disclosure of personal information gathered by us in ordinary course of business. We respect the privacy of visitors to this Web site and understand...
Innovative Process Research Novel Chemistry Novel Routes of Synthesis. Process elegance. Cost Effective Technology Development Technology indigenization Import substitution. Commercial plant compliance. Green & Safe...
New Drug Discovery (Medicinal Chemistry division): Natco works for the patient. The core philosophy of Natco’s drug discovery program is to focus on the unmet needs of patients, especially in areas of cancer and make specialty medicines available...
IP Management In-House management of generation/identification & protection. Coordination during patent prosecution. Patent vigilance on competitor applications. Coordination of local/global patent litigation.
Analytical R&D capabilities at Natco: The Analytical R & D (ARD) caters to API, Formulations development for generics as well as NCEs. The ARD has ability to support small molecules, peptides and non-biological complex drugs. We also have...
Collaborative research & development Institutional Collaboration. Contract Research. Specialty Synthetic & Analytical services. Contract process development & scale-up. Co-development of NCEs & partnerships New Drug Discovery...
At Natco we strongly believe that our employees are an integral part of our growth story and value them as our most important asset. Here are a few short excerpts from our employees, talking about what it’s like to work at Natco.
The Natco family currently consists of around 5000 employees. We provide a stimulating and challenging work environment to our employees, who get the opportunity to work on state-of-the-art technologies and deliver affordable and life saving drugs...
Natco believes that sustainable development, in any environment, has to be a participatory process, with employees and local population, being the biggest stakeholder. We work closely with the local community to keep the air, water and land both...
Our facilities are WHO compliant and approved by other global regulatory bodies. We have been progressively establishing ISO14001:2015 compliant Environmental Management System and OHSAS-45001:2018 compliant Occupational Health and Safety Management...
The objective of the award winning Natco Trust, the corporate social responsibility wing of Natco Pharma Limited (founded 1995), is to repay society, people and the environment. Over the years, the Trust has widened its coverage in line with the...
For Institutional Investors & Research Analysts Mr. Rajeev Menon Manager - Investor Relations r.menon@natcopharma.co.in Mr. Rajesh Chebiyam Executive Vice President, Crop Health Sciences Chief Investor Relation Officer...
[pagelist]
This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance...
Dear Shareholders, As you may be aware, the Ministry of Corporate Affairs (MCA) on May 10, 2012 vide reference no. G.S.R_352(E) notified the Investor Education Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying...
API Facility, Mekaguda Plant Location Natco Pharma Limited Chemical Division, Mekaguda (Village), Nandigama (Mandal), Rangareddy District, Telangana - 509 223, India. Capacity Current Plant capacity: 398 KL Up coming Plant...
API Facility, Chennai Plant Location Natco Pharma Limited, Chemical Division, No-74/7B, Vaikkadu TPP Salai, Manali, Chennai – 600 103, India. Phone: +91-44-29011779/7299009981/82/83/84 Capacity Current Plant capacity: 100...
Formulations Facility, Kothur Plant Location Natco Pharma Limited, Kothur (Post), Kothur (Mandal), Rangareddy District, Telangana - 509 228, India Plant Size Over All Plant Area: 17 Acres Built-Up Area: 4.3...
Formulations Facility, Nagarjuna Sagar Plant Location Natco Pharma Limited, Pharma Division - Parenterals , Vijayapuri North, Nagarjuna Sagar, Peddavura mandal, Nalgonda District - 508 202, Telangana, India Plant Size Total...
Formulations Facility, Dehradun Unit 6 Plant Location Natco Pharma Limited, Plot No: 19, Pharma City, Sidcul, Selaqui, Dehradun – 248 011, Uttarakhand, India. Plant Size Total Land Area: 2.14 Acres Built-Up Area: 0.9...
Formulations Facility, Dehradun Unit 7 Plant Location Natco Pharma Limited, Plot No: A3, UPSIDC Ind.Area, Selaqui, Dehradun – 248 011, Uttarakhand, India. Plant Size Total Land Area: 2.5 Acres Built-Up Area: 0.6...
Formulations Facility, Guwahati Plant Location Dag No. 749, 750, Vill: Kokjhar, Mirza, Guwahati – 781 125, Assam, India. Plant Size Total Land Area: 2.1 Acres Built-Up Area: 0.8 Acres Regulatory Approvals ...
Research Center (NRC) Location B-11,13&14 Industrial Estate Sanathnagar, Hyderabad Telangana-500 018. Capacity – Synthetic chemistry – Nano pharmaceuticals – New Drug Discovery – Animal house & cell...
Corporate Office Location Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India. Number of Employees: 218 Members Facilities APIs Mekaguda Chennai Formulations Kothur ...
Contract Manufacturing Facility, Nagarjuna Sagar Plant Location. Natco Pharma Limited-Pharma Division - Parenterals, Vijayapuri North, Nagarjuna Sagar, Nalgonda District Telangana-508 202. India. Regulatory Approvals ...
Contract Manufacturing Facility, Dehradun Unit 6 Plant Location Natco Pharma Limited - Pharma Division, Plot No. 19, Pharma City Selaqui Industrial Area, Vikas Nagar Dehradun-248 011, India. Regulatory Approvals WHO...
Contract Manufacturing Facility, Dehradun Unit 7 Plant Location Natco Pharma Limited, Plot No: A-3, UPSIDC Indl.Area, Selaqui, Dehradun – 248 011, India. Regulatory Approvals STATE GMP WHO GMP EU...
NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...
Disclaimer - Important THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED IN THE UNITED STATES. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY NATCO PHARMA LIMITED (THE “COMPANY”) TO COMPLY WITH...
Dear Shareholders, Pursuant to Section 124(6) of the Companies Act, 2013 all shares in respect of which dividend remained unpaid or unclaimed for seven consecutive years or more, shall have to be transferred by the company to the demat account of...
Formulations Facility, Visakhapatnam Plant Location Natco Pharma Limited, Plot No: 89 & 90, JNPC SEZ, Ramky Pharma City, Parawada, Visakhapatnam. Andhra Pradesh – 531 019 Plant Size Over All Plant Area: 7.89 Acres (31892...
Natco products reach more than 40 countries globally. Key geographies include India, North America, Latin America, Asia Pacific, South East Asia & Middle East.Through our partneship driven model, our exports are primarily done by out-licensing...
Natco products reach more than 40 countries globally. Key geographies include India, North America, Latin America, Asia Pacific, South East Asia & Middle East.Through our partneship driven model, our exports are primarily done by out-licensing...
Natco Pharma Limited has informed the Exchange that the board of directors of the Company, at its meeting held November 5, 2018, have approved the buyback of fully paid-up equity shares of face value of Rs. 2/- (Rupees Two only) each of the Company...
Our facilities are WHO compliant and approved by other global regulatory bodies. We have been progressively establishing ISO14001:2004 compliant Environmental Management System and OHSAS-18001:2007 compliant Occupational Health and Safety Management...
[vc_row][vc_column offset="vc_hidden-lg vc_hidden-md vc_hidden-sm vc_hidden-xs"][vc_column_text] Natco Pharma Inc Financial Report FY 2023-24 View PDF Financial Report FY 2022-23 View PDF Financial Report FY...
Quarterly Results Quarterly Results 2024 - 2025 Transcripts - Earnings Call 2024 – 2025 Quarter 2 report for the year 2024 – 2025 Quarter 1 report for the year 2024 – 2025 Q2 FY25...
NATCO has launched Cardiology and Diabetology (CnD) division (in early 2017), keeping in mind our mission of making specialty medicines accessible to all. Our current portfolio of products include: The cardiovascular range which offers a...
Natco’s Crop Health Science’s product portfolio consists of a range of innovative chemicals and biological pest management solutions for safe and efficient management of insects, diseases and weeds across a broad range of crops. Our plant growth...
Technical Facility, Attivaram Plant Location Natco Pharma Limited, Crop Health Science Division, Technical Unit Plot No. 29, Sy no.56P & 60P APIIC Industrial Park Attivaram, Dist.Nellore-524421 (AP) Tel:...
Formulations Facility, Attivaram Plant Location Natco Pharma Limited, Crop Health Science Division, Formulation Unit Plot No. 3& 8/1, Sy no.56P & 60P APIIC Industrial Park Attivaram, Dist.Nellore-524421 (AP) Tel:...
Natco has proven technical and operational expertise of over two decades in developing and commercialising niche APIs. Our unwavering commitment to quality; cGMP compliance to deliver affordable drug substances with novelty, and improving market...
For Retail Investors & Shareholders Mr. Ch. Venkat Ramesh Company Secretary & Compliance Officer PH: +91-40-23547532 Email: investors@natcopharma.co.in Registrar & Share Transfer Agents Venture Capital and...
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Our...
Shareholding Pattern 2024 Shareholding Pattern September 2024 Shareholding Pattern June 2024 Shareholding Pattern March 2024 Shareholding Pattern 2023 Shareholding Pattern December...
...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:39:"The image for the banner (1500 x...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:23:"The text for the...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:57:"The text for the quality and regulatory approvals...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:14:"The...
a:14:{s:10:"aria-label";s:0:"";s:4:"type";s:6:"select";s:12:"instructions";s:20:"The type of...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:24:"The name of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:28:"The location of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:39:"The number of employees at the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:7:"wysiwyg";s:12:"instructions";s:28:"The capacity of the...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:42:"The regulatory authorities of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:40:"The regulatory authority of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:7:"wysiwyg";s:12:"instructions";s:31:"The other stats of the...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:27:"The gallery of the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:48:"The image for the facility gallery (464 x...
a:14:{s:10:"aria-label";s:0:"";s:4:"type";s:6:"select";s:12:"instructions";s:60:"Please select the background colour for the facility...
...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:55:"The quality and regulatory approvals for the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:54:"The name of the regulatory approval for the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:68:"The image of the regulatory approval for the facilities (192 x...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:13:"The...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:24:"The name of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:28:"The position of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:39:"The profile description of the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:40:"The image of the director (176 x 181...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:19:"The management...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:45:"The name of the person on the management...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:49:"The position of the person on the management...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:41:"The name of the investor relations...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:45:"The position of the investor relations...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:45:"The position of the investor relations...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:40:"The name of the corporate affairs...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:41:"The email of the corporate affairs...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:44:"The position of the corporate affairs...
...
...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:38:"The text for the 'Our Mission'...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:57:"The image for the 'Our Mission' section (Max 240px...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:44:"The text for the 'Heritage Timeline'...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:64:"The image for the 'Heritage Timeline' section (Max 1000px...
...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:8:"The...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:11:"date_picker";s:12:"instructions";s:25:"The date of the news...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:26:"The title of the news...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:32:"The description of the news...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:40:"The image of the news post (280 x...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:13:"The...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:24:"The name of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:31:"The description of the...
...
...
...
...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:14:"A list of...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:20:"The title of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"file";s:12:"instructions";s:12:"The PDF...
...
...
...
...
...
...
...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:26:"The title for the...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:37:"The main image for the global...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:16:"The...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:35:"The image for the global...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:41:"The description for the global...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:64:"The website address for the global subsidiary (remember...
...
...
...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:36:"The contact name for the global...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:47:"The position of the contact for the global...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:44:"The email of the contact for the global...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:42:"The text for the Company Overview blue...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:47:"The text for the Come and Meet Us Next blue...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:53:"The image for the Meet Us Next blue box (280 x...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:67:"The video embed url for the Company Overview blue box (280 x...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:34:"The page sections on the home...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:24:"The title of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:31:"The description for the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:43:"The image for the section (Max 490px...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:9:"page_link";s:12:"instructions";s:33:"The link for the section's...
a:14:{s:10:"aria-label";s:0:"";s:4:"type";s:6:"select";s:12:"instructions";s:37:"The background colour for the...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:31:"The slideshow for the home...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:34:"The slideshow image (1500 x...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:26:"The text for the...
...
...
...
...
...
...
...
...
...
...
...
...
a:9:{s:10:"aria-label";s:0:"";s:4:"type";s:3:"tab";s:12:"instructions";s:16:"The...
a:9:{s:10:"aria-label";s:0:"";s:4:"type";s:3:"tab";s:12:"instructions";s:17:"The...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:17:"The...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:39:"The email address to send the resume...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:49:"The vacancy title to include in the email...
...
...
...
...
...
...
...
...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:19:"The API US...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:26:"The name of the US...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:42:"The therapeutic category of the US...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:19:"The API EU...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:26:"The name of the EU...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:42:"The therapeutic category of the EU...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:43:"The email of the person to contact for...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:16:"The...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The name of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:34:"The description of the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:28:"The image of the...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:52:"The position of the contact for this set of...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:35:"The contract manufacturing...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:23:"The S No of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:23:"The name of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:9:"page_link";s:12:"instructions";s:35:"The page the product should link...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:103:"The product ID this product should link to on the page link (corresponds to ID field on product's...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The strength of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:23:"The pack of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The location of the...
a:11:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"textarea";s:12:"instructions";s:39:"The contacts for contract...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:12:"The...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:59:"Unique product ID for linking products (lower case, 1...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:31:"The ingredients for the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The strength of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The dosage form of the...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The retail pack of the...
a:16:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"image";s:12:"instructions";s:42:"The image of the product (max width...
...
...
...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:41:"The contact name for this set of...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:52:"The position of the contact for this set of...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:49:"The email of the contact for this set of...
...
a:14:{s:10:"aria-label";s:0:"";s:4:"type";s:6:"select";s:12:"instructions";s:50:"The colour of the buttons and headings on the...
...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:47:"The international formulations products for...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The name of the USA...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:32:"The strengths of the USA...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:34:"The dosage form of the USA...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:27:"The pack of the USA...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:50:"The international formulations products for...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The name of the Canada...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:35:"The strengths of the Canada...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:37:"The dosage form of the Canada...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The pack of the Canada...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:50:"The international formulations products for...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The name of the Europe...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:35:"The strengths of the Europe...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:37:"The dosage form of the Europe...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:30:"The pack of the Europe...
...
a:13:{s:10:"aria-label";s:0:"";s:4:"type";s:8:"repeater";s:12:"instructions";s:67:"The international formulations products for Australia & New...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:47:"The name of the Australia & New Zealand...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:52:"The strengths of the Australia & New Zealand...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:54:"The dosage form of the Australia & New Zealand...
a:12:{s:10:"aria-label";s:0:"";s:4:"type";s:4:"text";s:12:"instructions";s:47:"The pack of the Australia & New Zealand...
...
a:10:{s:10:"aria-label";s:0:"";s:4:"type";s:5:"email";s:12:"instructions";s:65:"The email of the person to contact for International...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...